Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans A Target Trial Emulation
BMBCh, MS George N Ioannou, PhD Kristin Berry, PhD Nallakkandi Rajeevan, MS Yuli Li, MD Pradeep Mutalik, PhD Lei Yan, PhD David Bui, PharmD Francesca Cunningham, MPH Denise M Hynes, PhD, RN; Mazhgan Rowneki, MPH Amy Bohnert, PhD, MHS Edward J Boyko, MD, MPH Theodore J Iwashyna, PhD Matthew L Maciejewski, PhD Thomas F Osborne, MD Elizabeth M Viglianti, MD, MPH, MSc Mihaela Aslan, PhD Grant D Huang, PhD Kristina L Bajema
doi:10.7326/M23-1394
Background: COVID-19 has been linked to the development of many post-COVID-19 conditions (PCCs) after acute infection. Limited information is available on the effectiveness of oral antivirals used to treat acute COVID-19 in preventing the development of PCCs. Objective: To measure the effectiveness of outpatient treatment of COVID-19 with nirmatrelvir-ritonavir in preventing PCCs. Design: Retrospective target trial emulation study comparing matched cohorts receiving nirmatrelvir-ritonavir versus no treatment. Setting: Veterans Health Administration (VHA). Participants: Nonhospitalized veterans in VHA care who were at risk for severe COVID-19 and tested positive for SARS-CoV-2 during January through July 2022. Intervention: Nirmatrelvir-ritonavir treatment for acute COVID-19. Measurements: Cumulative incidence of 31 potential PCCs at 31 to 180 days after treatment or a matched index date, including cardiac, pulmonary, renal, thromboembolic, gastrointestinal, neurologic, mental health, musculoskeletal, endocrine, and general conditions and symptoms. Results: Eighty-six percent of the participants were male, with a median age of 66 years, and 17.5% were unvaccinated. Baseline characteristics were well balanced between participants treated with nirmatrelvir-ritonavir and matched untreated comparators. No differences were observed between participants treated with nirmatrelvir-ritonavir (n ¼ 9593) and their matched untreated comparators in the incidence of most PCCs examined individually or grouped by organ system, except for lower combined risk for venous thromboembolism and pulmonary embolism (subhazard ratio, 0.65 [95% CI, 0.44 to 0.97]; cumulative incidence difference, À0.29 percentage points [CI, À0.52 to À0.05 percentage points]). Limitations: Ascertainment of PCCs using International Classification of Diseases, 10th Revision codes may be inaccurate. Evaluation of many outcomes could have resulted in spurious associations with combined thromboembolic events by chance.
Conclusion: Out of 31 potential PCCs, only combined thromboembolic events seemed to be reduced by nirmatrelvir-ritonavir.
Author contributions are available at Annals.org.
References
Aggarwal, Molina, Beaty, Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of Omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study, Lancet Infect Dis,
doi:10.1016/S1473-3099(23)00011-7Arbel, Sagy, Hoshen, Nirmatrelvir use and severe Covid-19 outcomes during the Omicron surge, N Engl J Med,
doi:10.1056/NEJMoa2204919Austin, Cafri, Variance estimation when using propensity-score matching with replacement with survival or time-to-event outcomes, Stat Med,
doi:10.1002/sim.8502Ayoubkhani, Khunti, Nafilyan, Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study, BMJ,
doi:10.1136/bmj.n693Bajema, Berry, Streja, Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. veterans: target trial emulation studies with one-month and six-month outcomes, Ann Intern Med,
doi:10.7326/M22-3565Bernal, Da Silva, Musungaie, Study Group. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients, N Engl J Med,
doi:10.1056/NEJMoa2116044Bull-Otterson, Baca, Saydah, Post-COVID conditions among adult COVID-19 survivors aged 18-64 and ≥65 years-United States, March 2020-November 2021, MMWR Morb Mortal Wkly Rep,
doi:10.15585/mmwr.mm7121e1Butler, Hobbs, Gbinigie, Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial, Lancet,
doi:10.1016/S0140-6736(22)02597-1Carfi, Bernabei, Landi, Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19, JAMA,
doi:10.1001/jama.2020.12603Cohen, Ren, Heath, Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study, BMJ,
doi:10.1136/bmj-2021-068414Daugherty, Guo, Heath, Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study, BMJ,
doi:10.1136/bmj.n1098Dickerman, Gerlovin, Madenci, Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines in U.S. veterans, N Engl J Med,
doi:10.1056/NEJMoa2115463Dryden-Peterson, Kim, Kim, Nirmatrelvir plus ritonavir for early COVID-19 in a large U.S. health system: a populationbased cohort study, Ann Intern Med,
doi:10.7326/M22-2141Food, Administration, Paxlovid Patient Eligibility Screening Checklist Tool for Prescribers
Hammond, Leister-Tebbe, Gardner, EPIC-HR Investigators. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19, N Engl J Med,
doi:10.1056/NEJMoa2118542Hernán, Robins, Using big data to emulate a target trial when a randomized trial is not available, Am J Epidemiol,
doi:10.1093/aje/kwv254Ioannou, Locke, Green, Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: a target trial emulation study in the U.S. Veterans Affairs healthcare system, EClinicalMedicine,
doi:10.1016/j.eclinm.2022.101326Ioannou, Locke, Hare, COVID-19 vaccination effectiveness against infection or death in a national U.S. health care system: a target trial emulation study, Ann Intern Med,
doi:10.7326/M21-3256Katsoularis, Fonseca-Rodríguez, Farrington, Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study, Lancet,
doi:10.1016/S0140-6736(21)00896-5Lewnard, Mclaughlin, Malden, Effectiveness of nirmatrelvir-ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system, Lancet Infect Dis,
doi:10.1016/S1473-3099(23)00118-4Najjar-Debbiny, Gronich, Weber, Effectiveness of Paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients, Clin Infect Dis,
doi:10.1093/cid/ciac443Rosenbaum, Db, Reducing bias in observational studies using subclassification on the propensity score, J Am Stat Assoc,
doi:10.2307/2288398Statacorp, Chapter 11: Language syntax, Stata Manual
Wang, Porter, Maynard, Predicting risk of hospitalization or death among patients receiving primary care in the Veterans Health Administration, Med Care,
doi:10.1097/MLR.0b013e31827da95aWong, Au, Lau, Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the Omicron wave in Hong Kong: an observational study, Lancet,
doi:10.1016/S0140-6736(22)01586-0Xie, Bowe, Al-Aly, Berry, Aslan et al., Molnupiravir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records, BMJ,
doi:10.1136/bmj-2022-072705Xie, Bowe, Al-Aly, Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status, Nat Commun,
doi:10.1038/s41467-021-26513-3Yip, Lui, Lai, Impact of the use of oral antiviral agents on the risk of hospitalization in community coronavirus disease 2019 patients (COVID-19), Clin Infect Dis,
doi:10.1093/cid/ciac687{ 'indexed': { 'date-parts': [[2023, 11, 21]],
'date-time': '2023-11-21T00:31:08Z',
'timestamp': 1700526668994},
'reference-count': 40,
'publisher': 'American College of Physicians',
'issue': '11',
'funder': [ { 'DOI': '10.13039/100000738',
'name': 'U.S. Department of Veterans Affairs',
'doi-asserted-by': 'publisher',
'award': ['CSP #2038', 'C19 21-278', 'C19 21-279', 'RCS 10-391', 'RCS 21-136']}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'published-print': {'date-parts': [[2023, 11]]},
'DOI': '10.7326/m23-1394',
'type': 'journal-article',
'created': { 'date-parts': [[2023, 10, 30]],
'date-time': '2023-10-30T21:01:52Z',
'timestamp': 1698699712000},
'page': '1486-1497',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions '
'Among U.S. Veterans',
'prefix': '10.7326',
'volume': '176',
'author': [ { 'ORCID': 'http://orcid.org/0000-0003-1796-8977',
'authenticated-orcid': False,
'given': 'George N.',
'family': 'Ioannou',
'sequence': 'first',
'affiliation': [ { 'name': 'Research and Development and Division of Gastroenterology, '
'Veterans Affairs Puget Sound Health Care System, and Division of '
'Gastroenterology, University of Washington, Seattle, Washington '
'(G.N.I.)'}]},
{ 'given': 'Kristin',
'family': 'Berry',
'sequence': 'additional',
'affiliation': [ { 'name': 'Research and Development, Veterans Affairs Puget Sound Health '
'Care System, Seattle, Washington (K.B.)'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-2045-0872',
'authenticated-orcid': False,
'given': 'Nallakkandi',
'family': 'Rajeevan',
'sequence': 'additional',
'affiliation': [ { 'name': 'Veterans Affairs Cooperative Studies Program Clinical '
'Epidemiology Research Center (CSP-CERC), Veterans Affairs '
'Connecticut Healthcare System, West Haven, Connecticut, and Yale '
'Center for Medical Informatics, Yale School of Medicine, New '
'Haven, Connecticut (N.R., P.M.)'}]},
{ 'given': 'Yuli',
'family': 'Li',
'sequence': 'additional',
'affiliation': [ { 'name': 'Veterans Affairs Cooperative Studies Program Clinical '
'Epidemiology Research Center (CSP-CERC), Veterans Affairs '
'Connecticut Healthcare System, West Haven, Connecticut (Y.L.)'}]},
{ 'ORCID': 'http://orcid.org/0009-0002-4573-4617',
'authenticated-orcid': False,
'given': 'Pradeep',
'family': 'Mutalik',
'sequence': 'additional',
'affiliation': [ { 'name': 'Veterans Affairs Cooperative Studies Program Clinical '
'Epidemiology Research Center (CSP-CERC), Veterans Affairs '
'Connecticut Healthcare System, West Haven, Connecticut, and Yale '
'Center for Medical Informatics, Yale School of Medicine, New '
'Haven, Connecticut (N.R., P.M.)'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-4779-2688',
'authenticated-orcid': False,
'given': 'Lei',
'family': 'Yan',
'sequence': 'additional',
'affiliation': [ { 'name': 'Veterans Affairs Cooperative Studies Program Clinical '
'Epidemiology Research Center (CSP-CERC), Veterans Affairs '
'Connecticut Healthcare System, West Haven, Connecticut, and '
'Department of Biostatistics, Yale School of Public Health, New '
'Haven, Connecticut (L.Y.)'}]},
{ 'given': 'David',
'family': 'Bui',
'sequence': 'additional',
'affiliation': [ { 'name': 'Veterans Affairs Portland Health Care System, Portland, Oregon '
'(D.B.)'}]},
{ 'given': 'Francesca',
'family': 'Cunningham',
'sequence': 'additional',
'affiliation': [ { 'name': 'Veterans Affairs Center for Medication Safety - Pharmacy Benefit '
'Management (PBM) Services, Hines, Illinois (F.C.)'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-6436-7157',
'authenticated-orcid': False,
'given': 'Denise M.',
'family': 'Hynes',
'sequence': 'additional',
'affiliation': [ { 'name': 'Center of Innovation to Improve Veteran Involvement in Care '
'(CIVIC), Veterans Affairs Portland Healthcare System, Portland, '
'Oregon; Health Management and Policy, School of Social and '
'Behavioral Health Sciences, College of Public Health and Human '
'Sciences, Oregon State University, Corvallis, Oregon; and Health '
'Data and Informatics Program, Center for Quantitative Life '
'Sciences, Oregon State University, Corvallis, Oregon (D.M.H.)'}]},
{ 'given': 'Mazhgan',
'family': 'Rowneki',
'sequence': 'additional',
'affiliation': [ { 'name': 'Center of Innovation to Improve Veteran Involvement in Care '
'(CIVIC), Veterans Affairs Portland Healthcare System, Portland, '
'Oregon (M.R.)'}]},
{ 'given': 'Amy',
'family': 'Bohnert',
'sequence': 'additional',
'affiliation': [ { 'name': 'Center for Clinical Management Research, Veterans Affairs Ann '
'Arbor Healthcare System, and Department of Anesthesiology, '
'University of Michigan, Ann Arbor, Michigan (A.B.)'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-3695-192X',
'authenticated-orcid': False,
'given': 'Edward J.',
'family': 'Boyko',
'sequence': 'additional',
'affiliation': [ { 'name': 'Seattle Epidemiologic Research and Information Center, Veterans '
'Affairs Puget Sound Health Care System, Seattle, Washington '
'(E.J.B.)'}]},
{ 'given': 'Theodore J.',
'family': 'Iwashyna',
'sequence': 'additional',
'affiliation': [ { 'name': 'Center for Clinical Management Research, Veterans Affairs Ann '
'Arbor Healthcare System, Ann Arbor, Michigan, and Schools of '
'Medicine and Public Health, Johns Hopkins University, Baltimore, '
'Maryland (T.J.I.)'}]},
{ 'ORCID': 'http://orcid.org/0000-0003-1765-5938',
'authenticated-orcid': False,
'given': 'Matthew L.',
'family': 'Maciejewski',
'sequence': 'additional',
'affiliation': [ { 'name': 'Center of Innovation to Accelerate Discovery and Practice '
'Transformation, Durham Veterans Affairs Medical Center; '
'Department of Population Health Sciences, Duke University School '
'of Medicine; and Duke-Margolis Center for Health Policy, Duke '
'University, Durham, North Carolina (M.L.M.)'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-8896-2487',
'authenticated-orcid': False,
'given': 'Thomas F.',
'family': 'Osborne',
'sequence': 'additional',
'affiliation': [ { 'name': 'Veterans Affairs Palo Alto Health Care System, Palo Alto, '
'California, and Department of Radiology, Stanford University '
'School of Medicine, Stanford, California (T.F.O.)'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-7439-6322',
'authenticated-orcid': False,
'given': 'Elizabeth M.',
'family': 'Viglianti',
'sequence': 'additional',
'affiliation': [ { 'name': 'Center for Clinical Management Research, Veterans Affairs Ann '
'Arbor Healthcare System, and Department of Internal Medicine, '
'University of Michigan, Ann Arbor, Michigan (E.M.V.)'}]},
{ 'given': 'Mihaela',
'family': 'Aslan',
'sequence': 'additional',
'affiliation': [ { 'name': 'Veterans Affairs Cooperative Studies Program Clinical '
'Epidemiology Research Center (CSP-CERC), Veterans Affairs '
'Connecticut Healthcare System, West Haven, Connecticut, and '
'Department of Medicine, Yale School of Medicine, New Haven, '
'Connecticut (M.A.)'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-1217-0002',
'authenticated-orcid': False,
'given': 'Grant D.',
'family': 'Huang',
'sequence': 'additional',
'affiliation': [ { 'name': 'Office of Research and Development, Veterans Health '
'Administration, Washington, DC (G.D.H.)'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-3229-5590',
'authenticated-orcid': False,
'given': 'Kristina L.',
'family': 'Bajema',
'sequence': 'additional',
'affiliation': [ { 'name': 'Veterans Affairs Portland Health Care System, and Division of '
'Infectious Diseases, Department of Medicine, Oregon Health & '
'Science University, Portland, Oregon (K.L.B.).'}]}],
'member': '4285',
'reference': [ {'key': 'r1-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.n1648'},
{'key': 'r2-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41467-021-26513-3'},
{'key': 'r3-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41586-021-03553-9'},
{'key': 'r4-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41591-022-01689-3'},
{'key': 'r5-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.n693'},
{ 'key': 'r6-M231394',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(20)32656-8'},
{'key': 'r7-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jama.2020.12603'},
{'key': 'r8-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.n1098'},
{ 'key': 'r9-M231394',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(21)00896-5'},
{'key': 'r10-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41591-020-0968-3'},
{'key': 'r11-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41591-021-01283-z'},
{'key': 'r12-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41579-022-00846-2'},
{'key': 'r13-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.15585/mmwr.mm7121e1'},
{'key': 'r15-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.7326/M22-3565'},
{ 'key': 'r16-M231394',
'doi-asserted-by': 'publisher',
'DOI': '10.1001/jamanetworkopen.2023.31249'},
{'key': 'r18-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2118542'},
{ 'key': 'r19-M231394',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(22)02597-1'},
{ 'key': 'r20-M231394',
'doi-asserted-by': 'publisher',
'DOI': '10.1001/jamainternmed.2023.0743'},
{'key': 'r21-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj-2022-074572'},
{'key': 'r22-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/aje/kwv254'},
{'key': 'r23-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2115463'},
{'key': 'r24-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.7326/M21-3256'},
{ 'key': 'r25-M231394',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.eclinm.2022.101326'},
{'key': 'r26-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s10654-017-0293-4'},
{'key': 'r32-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.2307/2288398'},
{'key': 'r33-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj-2021-068993'},
{'key': 'r34-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj-2021-068414'},
{'key': 'r35-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.319.7223.1492'},
{'key': 'r37-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/sim.8502'},
{ 'key': 'r38-M231394',
'doi-asserted-by': 'publisher',
'DOI': '10.1097/00001648-200009000-00011'},
{ 'key': 'r39-M231394',
'doi-asserted-by': 'publisher',
'DOI': '10.1097/MLR.0b013e31827da95a'},
{'key': 'r40-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2116044'},
{ 'key': 'r41-M231394',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S1473-3099(23)00011-7'},
{'key': 'r42-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2204919'},
{'key': 'r43-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.7326/M22-2141'},
{'key': 'r44-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/cid/ciac443'},
{ 'key': 'r45-M231394',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(22)01586-0'},
{'key': 'r46-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/cid/ciac687'},
{ 'key': 'r47-M231394',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S1473-3099(23)00118-4'},
{'key': 'r48-M231394', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj-2022-072705'}],
'container-title': 'Annals of Internal Medicine',
'original-title': [],
'language': 'en',
'deposited': { 'date-parts': [[2023, 11, 20]],
'date-time': '2023-11-20T22:05:57Z',
'timestamp': 1700517957000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.acpjournals.org/doi/10.7326/M23-1394'}},
'subtitle': ['A Target Trial Emulation'],
'short-title': [],
'issued': {'date-parts': [[2023, 11]]},
'references-count': 40,
'journal-issue': {'issue': '11', 'published-print': {'date-parts': [[2023, 11]]}},
'alternative-id': ['10.7326/M23-1394'],
'URL': 'http://dx.doi.org/10.7326/M23-1394',
'relation': {},
'ISSN': ['0003-4819', '1539-3704'],
'subject': ['General Medicine', 'Internal Medicine'],
'container-title-short': 'Ann Intern Med',
'published': {'date-parts': [[2023, 11]]}}
